Relationship between glucocorticoids and viral load during the Omicron wave in mainland China

Guangxu Bai1,2, Yan Li1,2, Yang Liu1,2

  • 1Emergency Department, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, 100730, China.

Virology Journal
|November 23, 2023
PubMed

Insights

Glucocorticoids did not accelerate coronavirus disease 19 (COVID-19) viral clearance or affect mortality. However, glucocorticoid therapy may aid in COVID-19 negative conversion and reduce inflammatory factors, potentially by regulating the immune response.

Area of Science:

  • Infectious Diseases
  • Pharmacology
  • Immunology

Background:

  • Coronavirus disease 19 (COVID-19) remains a significant global health concern.
  • The role of glucocorticoids in COVID-19 treatment, specifically regarding viral clearance and patient prognosis, is debated.
  • This study investigates the association between glucocorticoid use and COVID-19 viral load.

Purpose of the Study:

  • To examine the relationship between glucocorticoid therapy and COVID-19 viral load dynamics.
  • To assess the impact of glucocorticoids on viral clearance and patient outcomes in COVID-19.
  • To understand the potential immunomodulatory effects of glucocorticoids in COVID-19 patients.

Main Methods:

  • Retrospective analysis of COVID-19 patients admitted to Peking Union Medical College Hospital (late 2022-early 2023).
  • Collection of baseline, clinical, laboratory, immunological, and daily viral load data.
  • Statistical analysis using Kolmogorov-Smirnov test, Student's t test, Mann-Whitney U test, and Cox proportional-hazards model.

Main Results:

  • Glucocorticoids did not significantly alter COVID-19 viral clearance, replication, or 28-day/in-hospital mortality.
  • Glucocorticoid therapy was associated with a favorable factor for COVID-19 negative conversion in the Cox model.
  • Patients on glucocorticoids exhibited significantly decreased levels of inflammatory factors.

Conclusions:

  • Glucocorticoids may not directly impact SARS-CoV-2 viral load but could improve clinical symptoms.
  • The therapeutic benefit of glucocorticoids might stem from modulating the immune response to inflammatory storms.
  • Further research into the immunoregulatory mechanisms of glucocorticoids in COVID-19 is warranted.
Abstract

Related Concept Videos

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of many...
Subviral Agents01:29

Subviral Agents

Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Coronavirus01:29

Coronavirus

Coronaviruses, including the severe acute respiratory syndrome coronavirus (SARS-CoV), are enveloped viruses characterized by their single-stranded, positive-sense RNA genome and helical nucleocapsid structure. The hallmark of these viruses is their club-shaped spike (S) glycoproteins that protrude from the viral envelope, facilitating attachment to host cells. Typically, coronaviruses infect the upper respiratory tract, often causing mild or asymptomatic disease. However, certain strains like...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...